Track Dermata Therapeutics Inc. Common Stock — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Dermata Therapeutics Inc. Common Stock DRMA · Stock Open Dermata Therapeutics Inc. Common Stock in new tab

1.14 USD
Add to portfolio
EPS
-4.27
P/B
1.33
ROE
-183.89
Beta
0.69
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 18, 2026
EPS-4.27
Book Value0.87
Price to Book1.33
% Insiders27.354%
Estimates
Forward P/E-0.30
Forward EPS-3.87

DCF Valuation

Tweak assumptions to recompute fair value for Dermata Therapeutics Inc. Common Stock (DRMA)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Dermata Therapeutics Inc. Common Stock Logo Dermata Therapeutics Inc. Common Stock Analysis (DRMA)

United States Health Care Official Website Stock

Is Dermata Therapeutics Inc. Common Stock a good investment? Dermata Therapeutics Inc. Common Stock (DRMA) is currently trading at 1.14 USD.

Earnings Schedule: Dermata Therapeutics Inc. Common Stock is expected to release its next earnings report on Nov. 18, 2026. The market consensus estimate for Forward EPS is -3.87.

Investor FAQ

Does Dermata Therapeutics Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Dermata Therapeutics Inc. Common Stock?

Dermata Therapeutics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 18, 2026. The company currently has a trailing EPS of -4.27.

Company Profile

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Exchange Ticker
NMS (United States) DRMA
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
March 14, 2023 0.06
May 16, 2024 0.07
Aug. 1, 2025 1:10
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion